Angelo Abiy Tadesse, Alemayehu Daniel Shiferaw
Department of Nursing, Mizan Tepi University, Mizan Aman, Ethiopia.
Patient Prefer Adherence. 2021 Feb 12;15:299-308. doi: 10.2147/PPA.S298594. eCollection 2021.
Good adherence to antiretroviral therapy (ART) suppresses the viral load, reconstitutes the immune system, and decreases opportunistic infections among HIV-positive patients. However, adherence to ART is still challenging in developing countries such as Ethiopia. The study, therefore, aimed to assess adherence and its associated factors among HIV-positive patients on ART in southern Ethiopia in 2020.
A cross-sectional study was conducted among 329 randomly selected participants. A structured questionnaire was used to collect the data through a face-to-face interview from January 23 to February 23, 2020. Data were entered into Epidata 3.1 and exported to SPSS version 21 for analysis. Bivariate and multivariate logistic regressions were used for analysis. A -value of less than 0.05 was considered significant in a multivariate logistic regression analysis.
In total, 274 patients (83.3%) had good adherence to ART, while 16.7% did not adhere. Age between 39 and 49 years old (AOR=0.068, 95% CI 0.008, 0.578), urban residency (AOR=5.186, 95% CI 1.732, 15.529), an educational status of being unable to read and write (AOR=0.097, 95% CI 0.012, 0.771), an educational status of reading and writing with no formal education (AOR=0.056, 95% CI 0.006, 0.532), comorbidity (AOR=0.042, 95% CI 0.013, 0.139), disclosure (AOR=3.583, 95% CI 1.008, 12.739), WHO clinical stage II (AOR=0.098, 95% CI 0.021, 0.453), and CD4 count ≥500 cells/mm (AOR=5.634, 95% CI 1.203, 26.383) were significantly associated with adherence to ART among patients.
The adherence of patients to ART is relatively low compared to other studies conducted in different regions. Age 39-49 years, educational status, comorbidity, and WHO clinical staging were negatively associated with ART adherence. Residency, disclosure, and current CD4 category greater than or equal to 500 cells/mm were positively associated with adherence. Good counseling to patients from rural areas, with low educational status, and with low CD4 counts, and on the importance of disclosure, is recommended and should be given by professionals.
良好地坚持抗逆转录病毒疗法(ART)可抑制病毒载量、重建免疫系统并减少HIV阳性患者的机会性感染。然而,在埃塞俄比亚等发展中国家,坚持ART治疗仍具有挑战性。因此,本研究旨在评估2020年埃塞俄比亚南部接受ART治疗的HIV阳性患者的依从性及其相关因素。
对329名随机选取的参与者进行了一项横断面研究。2020年1月23日至2月23日,通过面对面访谈使用结构化问卷收集数据。数据录入Epidata 3.1并导出至SPSS 21版进行分析。采用双变量和多变量逻辑回归进行分析。在多变量逻辑回归分析中,P值小于0.05被认为具有统计学意义。
总共有274名患者(83.3%)对ART治疗依从性良好,而16.7%的患者不依从。年龄在39至49岁之间(调整后比值比[AOR]=0.068,95%置信区间[CI] 0.008,0.578)、城市居住(AOR=5.186,95% CI 1.732,15.529)、无法读写的教育程度(AOR=0.097,95% CI 0.012,0.771)、读写但无正规教育的教育程度(AOR=0.056,95% CI 0.006,0.532)、合并症(AOR=0.042,95% CI 0.013,0.139)、信息披露(AOR=3.583,95% CI 1.008,12.739)、世界卫生组织临床分期II期(AOR=0.098,95% CI 0.021,0.453)以及CD4细胞计数≥500个/立方毫米(AOR=5.634,95% CI 1.203,26.383)与患者对ART治疗的依从性显著相关。
与在不同地区进行的其他研究相比,患者对ART治疗的依从性相对较低。39 - 49岁的年龄、教育程度、合并症以及世界卫生组织临床分期与ART治疗依从性呈负相关。居住情况、信息披露以及当前CD4类别大于或等于500个/立方毫米与依从性呈正相关。建议由专业人员对来自农村地区、教育程度低且CD4细胞计数低的患者进行关于信息披露重要性的良好咨询。